N/A N=353 Randomized Supportive Care

Smart Linkage-to-HIV Care Via a Smartphone App

HIV Infections · Viral Load · Patient Compliance · Antiretroviral Therapy · Cell Phone

Bottom Line

View on ClinicalTrials.gov: NCT02756949 ↗

Enrolled (actual)

353

Serious AEs

0.0%

Results posted

Oct 2019

Primary outcome: Primary: Linkage to HIV Care (Indicated by a HIV-related Laboratory Blood Test Within 8 Months) — 88; 74; 93; 90 Participants

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Smartphone application (Other); Smartphone (Device)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: World Bank
Primary completion: Feb 2017

Outcome Measures

Outcome	Result	p-value
PRIMARY Linkage to HIV Care (Indicated by a HIV-related Laboratory Blood Test Within 8 Months)	88; 74; 93; 90	—
SECONDARY Linkage to HIV Care Among Young People (Indicated by a HIV-related Laboratory Blood Test Within 8 Months)	44; 22; 39; 47	—

Summary

This randomized controlled trial evaluates the provision of individual patient laboratory results to newly diagnosed HIV positive smartphone users through a secure application (app) as a method to get them linked to and retained in care, and engage with educational materials purposefully developed to explain their results. Message prompts will also be used to alert patients that their results are ready and provide information on how to link to care, and assistance to re-link to care if they fall out of the health system for any reason. Prompts will be sent to patients to remind health care workers if they are due for repeat laboratory monitoring. The primary endpoint is linkage to care (a HIV-related laboratory test) at 6 months. The control group received standard of care.

Eligibility Criteria

Inclusion Criteria

Newly diagnosed HIV positive clients presenting at selected public health facilities, irrespective of CD4 count
Access to an Android smartphone with data
Willing to pay the (very small) cost to access their laboratory result
Age - 18 years and older
Proof of ID/passport/refugee number (for identification/security, and to confirm the single patient identifier)
Can read English or Zulu
Ability and willingness to sign informed consent

Exclusion Criteria

Clients presenting for antenatal care services, as these women will be enrolled in the national MomConnect program
Refusal to participate

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02756949). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.